| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-05-0219 |
| P698 | PubMed publication ID | 16397053 |
| P50 | author | George Sledge | Q92594250 |
| Beamon Agarwal | Q106263700 | ||
| Kathy D. Miller | Q91794468 | ||
| P2093 | author name string | Michael Miller | |
| Sunil Badve | |||
| Gary D Hutchins | |||
| Qi-Huang Zheng | |||
| Sanjana Mehrotra | |||
| Bruce H Mock | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 281-288 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | A physiologic imaging pilot study of breast cancer treated with AZD2171. | |
| P478 | volume | 12 |
| Q43515124 | Anti-tumour and anti-vascular effects of cediranib (AZD2171) alone and in combination with other anti-tumour therapies |
| Q37396438 | Antiangiogenic therapy for metastatic breast cancer: current status and future directions |
| Q37385416 | Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma |
| Q39036230 | Clinical Pharmacokinetics and Pharmacodynamics of Cediranib |
| Q37486753 | Current status of cediranib: the rapid development of a novel anti-angiogenic therapy. |
| Q36893738 | Deciphering the molecular basis of breast cancer metastasis with mouse models |
| Q39397672 | FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft model |
| Q37729815 | Imaging ovarian cancer and peritoneal metastases--current and emerging techniques |
| Q39841564 | In Vivo Measurements of Tumor Metabolism and Growth after Administration of Enzastaurin Using Small Animal FDG Positron Emission Tomography |
| Q36675387 | Kidney cancer therapy: new perspectives and avenues |
| Q37019264 | Molecular imaging as a tool for translating breast cancer science |
| Q39642439 | Monitoring the Longitudinal Intra-tumor Physiological Impulse Response to VEGFR2 Blockade in Breast Tumors Using DCE-CT |
| Q34158454 | Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies |
| Q49966031 | The role of Cediranib in ovarian cancer |
| Q79314678 | The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients |
| Q36658188 | The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis |
| Q31092577 | Tracking normalization of brain tumor vasculature by magnetic imaging and proangiogenic biomarkers |
| Q35100064 | β-Catenin is required for Ron receptor-induced mammary tumorigenesis |
Search more.